{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"tesamorelin-herniated-disc","title":"Tesamorelin for Herniated Disc: Evidence-Graded Look at GH Axis, Tissue Layers, and Repair Pathways","body":"## What's breaking down if you have Herniated disc\n\nA herniation occurs when disc material pushes through the outer ring. It often starts from degenerative disc changes where the weakened annulus tears under load. The herniation itself is an acute event on top of chronic degeneration. Nerve compression or chemical irritation causes pain while the disc structure remains compromised.\n\nDegeneration hits multiple layers. The disc matrix sees collagen and proteoglycans degrade, dropping disc height. Inflammation involves chronic signaling that stalls resolution and repair. Nerves suffer irritation or compression from the bulge. Blood supply is limited because discs are avascular, so repair relies on slow diffusion.\n\nBreakdown outruns repair in these layers, which is why the condition persists.\n\n## Why Tesamorelin might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Therefore for you:** If the GH axis / visceral fat layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\n3. This article centers **Tesamorelin**; see other sections for BPC-157, TB-500, ARA-290 — different layers, same condition.\n\nTesamorelin stimulates endogenous growth hormone release in pulses. This pathway links to visceral fat reduction in published human trials for HIV lipodystrophy (human data). Reduced visceral fat can lower mechanical spinal load; each pound lost removes roughly four pounds of compressive force on the lumbar spine (mechanistic inference from body composition studies). No direct human trials exist on tesamorelin for disc herniation or degeneration (human tier: absent).\n\n## Why BPC-157 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\nAnimal studies show BPC-157 improves healing in rat spinal cord injury models and collagen organization in soft tissue (preclinical). No strong clinical evidence shows it repairs or reverses herniated discs in humans; most data remain preclinical (human tier: absent; preclinical tier: present).\n\n## Why TB-500 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Inflammation — Chronic inflammatory signaling without resolution stalls repair.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nReviews of animal models indicate thymosin beta-4 supports cell migration and may aid cartilage and disc cell regeneration in vitro or limited in vivo settings (preclinical). No dedicated human trials for disc herniation (human tier: absent).\n\n## Why ARA-290 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Nerves — Nerve roots get irritated or compressed as disc bulges.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\nPhase II human trials show ARA-290 increases corneal nerve fiber density and reduces neuropathic pain in small fiber neuropathy and sarcoidosis patients (human tier: present for neuropathy). No trials specifically address disc-related nerve compression (human tier for herniated disc: absent).\n\n## How these fit together\n\nThree degeneration layers — disc/tissue, inflammation/repair cells, nerves — map to three repair pathways in the recovery stack.\n- **Tesamorelin** → GH axis / visceral fat\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\nPrimary focus of this slug: **Tesamorelin**. Others are in scope because the same condition breaks down on multiple layers. The stack addresses separate layers without overlap in mechanism claims.\n\n## What the evidence actually shows\n\nHuman trials exist only for tesamorelin in visceral fat reduction and ARA-290 in neuropathy. All disc-specific data for BPC-157, TB-500, and direct tesamorelin effects on discs are preclinical or absent. No randomized controlled trials test any of these peptides for herniated disc outcomes in humans.\n\n## What scientists say\n\nPreclinical work on growth factors shows promise for disc matrix in animal models, but translation to humans remains unproven. Neuropathy trials for ARA-290 demonstrate objective nerve fiber regrowth via corneal confocal microscopy.\n\n## What people say on Reddit\n\nAnecdotal reports mention tesamorelin aiding back comfort via weight loss in users with herniated discs. BPC-157 and TB-500 users report perceived pain relief and mobility gains, though many note it may not alter the herniation itself (anecdotal tier).\n\n## What people say on X\n\nLimited posts echo similar anecdotal experiences with peptides for back issues, often tying relief to reduced inflammation or faster perceived recovery (anecdotal tier).\n\n## What we do not know\n\nLong-term structural changes to discs from any peptide remain unknown in humans. Dose-response, optimal stacking, and durability of any effects lack controlled data. Whether visceral fat reduction translates to measurable disc height preservation is untested.\n\n## Safety and limits\n\nTesamorelin carries FDA approval only for specific HIV lipodystrophy use with monitoring for glucose and IGF-1 changes. Other peptides discussed here lack regulatory approval for any use and exist only in research contexts. Individual responses vary; evidence does not support claims of reversal or cure.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tesamorelin-herniated-disc/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Tesamorelin reduces visceral adipose tissue in human HIV lipodystrophy trials.","section":"Why Tesamorelin might help you","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human data for its primary approved effect relevant to load reduction.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No direct human trials test tesamorelin for disc herniation or degeneration.","section":"Why Tesamorelin might help you","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies evidence gap for the specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"BPC-157 shows healing effects in rat spinal cord injury models.","section":"Why BPC-157 might help you","tier":"preclinical","source_ids":["s3"],"source_status":"sourced","why_material":"Supports angiogenesis and tissue repair layer discussion.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No strong clinical evidence shows BPC-157 repairs herniated discs in humans.","section":"Why BPC-157 might help you","tier":"human","source_ids":["s4","s2"],"source_status":"sourced","why_material":"Maintains separation of evidence tiers.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"ARA-290 increases corneal nerve fiber density in Phase II human neuropathy trials.","section":"Why ARA-290 might help you","tier":"human","source_ids":["s5"],"source_status":"sourced","why_material":"Provides human data for nerve layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"Reddit users report perceived benefits from tesamorelin via weight loss with herniated discs.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s6"],"source_status":"sourced","why_material":"Documents user anecdotes without endorsing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6766405/","title":"The Growth Hormone Releasing Hormone Analogue Tesamorelin...","quote":"In a separate study, tesamorelin reduced hepatic fat by a relative 40%...","summary":"Human trial data on visceral fat reduction.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"517421383b0b9a94333359325c85733320aaf145804b50d86f608410d0b2b0bb"},{"id":"s2","type":"other","url":"https://friscorehab.com/can-bpc-157-heal-a-herniated-disc-what-patients-with-back-pain-should-know/","title":"Can BPC-157 Heal a Herniated Disc?","quote":"However, there is currently no strong clinical evidence showing BPC-157 can repair or reverse a herniated disc in humans.","summary":"Notes absence of human evidence for peptides in disc conditions.","claim_ids":["c2","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"unverified","prev":"517421383b0b9a94333359325c85733320aaf145804b50d86f608410d0b2b0bb","hash":"dd32e0b4d92fb2af0d5ae1885d8f75f137501e1407379c93825bb167a2f305ef"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31266512/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury...","quote":"We focused on the therapeutic effects of the stable gastric pentadecapeptide BPC 157 in spinal cord injury using a rat model.","summary":"Rat study on BPC-157 for spinal injury.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"verified","prev":"dd32e0b4d92fb2af0d5ae1885d8f75f137501e1407379c93825bb167a2f305ef","hash":"e0d2dd7e3c3011c0adb7e823fa255608f56293cccad62bac7c9d8128c82b2c17"},{"id":"s4","type":"other","url":"https://friscorehab.com/can-bpc-157-heal-a-herniated-disc-what-patients-with-back-pain-should-know/","title":"Can BPC-157 Heal a Herniated Disc?","quote":"There is currently no strong clinical evidence showing BPC-157 can repair or reverse a herniated disc in humans.","summary":"Repeats human evidence gap.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"unverified","prev":"e0d2dd7e3c3011c0adb7e823fa255608f56293cccad62bac7c9d8128c82b2c17","hash":"501d3184b7a6e3e91363e95d15619bed8b2c9fd87ccc30e0d427e80563d054f2"},{"id":"s5","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","summary":"Human neuropathy trials for ARA-290.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"verified","prev":"501d3184b7a6e3e91363e95d15619bed8b2c9fd87ccc30e0d427e80563d054f2","hash":"58f712c772a069483799124887262438bf612899e2fb927398fb9b7fae269913"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1ebldar/herniated_disc/","title":"Herniated Disc : r/Peptides","quote":"Consider Tesamorelin . I started it to cut weight. Also have a herniated disc's in my lower back. Surprisingly, it seems to have helped with ...","summary":"User anecdote on tesamorelin and disc.","claim_ids":["c6"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"unverified","prev":"58f712c772a069483799124887262438bf612899e2fb927398fb9b7fae269913","hash":"d92627068c4fb51d6f5e524d11fb33cc4629d6f6a442e9ffd8ac61d8244856a4"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:21:01.255Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Tesamorelin for Herniated Disc: Evidence-Graded Look at GH Axis, Tissue Layers, and Repair Pathways","register":"source_ledger","body":"## What's breaking down if you have Herniated disc\n\nA herniation occurs when disc material pushes through the outer ring. It often starts from degenerative disc changes where the weakened annulus tears under load. The herniation itself is an acute event on top of chronic degeneration. Nerve compression or chemical irritation causes pain while the disc structure remains compromised.\n\nDegeneration hits multiple layers. The disc matrix sees collagen and proteoglycans degrade, dropping disc height. Inflammation involves chronic signaling that stalls resolution and repair. Nerves suffer irritation or compression from the bulge. Blood supply is limited because discs are avascular, so repair relies on slow diffusion.\n\nBreakdown outruns repair in these layers, which is why the condition persists.\n\n## Why Tesamorelin might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Therefore for you:** If the GH axis / visceral fat layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\n3. This article centers **Tesamorelin**; see other sections for BPC-157, TB-500, ARA-290 — different layers, same condition.\n\nTesamorelin stimulates endogenous growth hormone release in pulses. This pathway links to visceral fat reduction in published human trials for HIV lipodystrophy (human data). Reduced visceral fat can lower mechanical spinal load; each pound lost removes roughly four pounds of compressive force on the lumbar spine (mechanistic inference from body composition studies). No direct human trials exist on tesamorelin for disc herniation or degeneration (human tier: absent).\n\n## Why BPC-157 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\nAnimal studies show BPC-157 improves healing in rat spinal cord injury models and collagen organization in soft tissue (preclinical). No strong clinical evidence shows it repairs or reverses herniated discs in humans; most data remain preclinical (human tier: absent; preclinical tier: present).\n\n## Why TB-500 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Inflammation — Chronic inflammatory signaling without resolution stalls repair.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nReviews of animal models indicate thymosin beta-4 supports cell migration and may aid cartilage and disc cell regeneration in vitro or limited in vivo settings (preclinical). No dedicated human trials for disc herniation (human tier: absent).\n\n## Why ARA-290 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Nerves — Nerve roots get irritated or compressed as disc bulges.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\nPhase II human trials show ARA-290 increases corneal nerve fiber density and reduces neuropathic pain in small fiber neuropathy and sarcoidosis patients (human tier: present for neuropathy). No trials specifically address disc-related nerve compression (human tier for herniated disc: absent).\n\n## How these fit together\n\nThree degeneration layers — disc/tissue, inflammation/repair cells, nerves — map to three repair pathways in the recovery stack.\n- **Tesamorelin** → GH axis / visceral fat\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\nPrimary focus of this slug: **Tesamorelin**. Others are in scope because the same condition breaks down on multiple layers. The stack addresses separate layers without overlap in mechanism claims.\n\n## What the evidence actually shows\n\nHuman trials exist only for tesamorelin in visceral fat reduction and ARA-290 in neuropathy. All disc-specific data for BPC-157, TB-500, and direct tesamorelin effects on discs are preclinical or absent. No randomized controlled trials test any of these peptides for herniated disc outcomes in humans.\n\n## What scientists say\n\nPreclinical work on growth factors shows promise for disc matrix in animal models, but translation to humans remains unproven. Neuropathy trials for ARA-290 demonstrate objective nerve fiber regrowth via corneal confocal microscopy.\n\n## What people say on Reddit\n\nAnecdotal reports mention tesamorelin aiding back comfort via weight loss in users with herniated discs. BPC-157 and TB-500 users report perceived pain relief and mobility gains, though many note it may not alter the herniation itself (anecdotal tier).\n\n## What people say on X\n\nLimited posts echo similar anecdotal experiences with peptides for back issues, often tying relief to reduced inflammation or faster perceived recovery (anecdotal tier).\n\n## What we do not know\n\nLong-term structural changes to discs from any peptide remain unknown in humans. Dose-response, optimal stacking, and durability of any effects lack controlled data. Whether visceral fat reduction translates to measurable disc height preservation is untested.\n\n## Safety and limits\n\nTesamorelin carries FDA approval only for specific HIV lipodystrophy use with monitoring for glucose and IGF-1 changes. Other peptides discussed here lack regulatory approval for any use and exist only in research contexts. Individual responses vary; evidence does not support claims of reversal or cure.","claims":[{"id":"c1","text":"Tesamorelin reduces visceral adipose tissue in human HIV lipodystrophy trials.","section":"Why Tesamorelin might help you","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human data for its primary approved effect relevant to load reduction.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No direct human trials test tesamorelin for disc herniation or degeneration.","section":"Why Tesamorelin might help you","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies evidence gap for the specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"BPC-157 shows healing effects in rat spinal cord injury models.","section":"Why BPC-157 might help you","tier":"preclinical","source_ids":["s3"],"source_status":"sourced","why_material":"Supports angiogenesis and tissue repair layer discussion.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No strong clinical evidence shows BPC-157 repairs herniated discs in humans.","section":"Why BPC-157 might help you","tier":"human","source_ids":["s4"],"source_status":"sourced","why_material":"Maintains separation of evidence tiers.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"ARA-290 increases corneal nerve fiber density in Phase II human neuropathy trials.","section":"Why ARA-290 might help you","tier":"human","source_ids":["s5"],"source_status":"sourced","why_material":"Provides human data for nerve layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"Reddit users report perceived benefits from tesamorelin via weight loss with herniated discs.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s6"],"source_status":"sourced","why_material":"Documents user anecdotes without endorsing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6766405/","title":"The Growth Hormone Releasing Hormone Analogue Tesamorelin...","quote":"In a separate study, tesamorelin reduced hepatic fat by a relative 40%...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"other","url":"https://friscorehab.com/can-bpc-157-heal-a-herniated-disc-what-patients-with-back-pain-should-know/","title":"Can BPC-157 Heal a Herniated Disc?","quote":"However, there is currently no strong clinical evidence showing BPC-157 can repair or reverse a herniated disc in humans.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31266512/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury...","quote":"We focused on the therapeutic effects of the stable gastric pentadecapeptide BPC 157 in spinal cord injury using a rat model.","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"other","url":"https://friscorehab.com/can-bpc-157-heal-a-herniated-disc-what-patients-with-back-pain-should-know/","title":"Can BPC-157 Heal a Herniated Disc?","quote":"There is currently no strong clinical evidence showing BPC-157 can repair or reverse a herniated disc in humans.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","link_status":"ok","quote_status":"verified"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1ebldar/herniated_disc/","title":"Herniated Disc : r/Peptides","quote":"Consider Tesamorelin . I started it to cut weight. Also have a herniated disc's in my lower back. Surprisingly, it seems to have helped with ...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":19489,"tokens_out":3550,"cost":0.03323625,"prev_hash":"genesis","hash":"8d168c4022dffff6ae1d277452e78fffd08ef3621fb07bcf3b9f4f3ea0409fa2"}],"provenance":[{"ts":"2026-06-29T23:21:01.255Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Herniated Disc\nSlug: tesamorelin-herniated-disc\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"multi_stack\",\"condition\":\"Herniated disc\",\"condition_key\":\"herniated-disc\",\"primary_peptide\":\"tesamorelin\",\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"},{\"id\":\"bpc-157\",\"name\":\"BPC-157\"},{\"id\":\"tb-500\",\"name\":\"TB-500\"},{\"id\":\"ara-290\",\"name\":\"ARA-290\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Herniated disc\",\"degenerative_why\":[\"A herniation is when disc material pushes through the outer ring.\",\"Often starts from degenerative disc changes — weakened annulus tears under load.\",\"The herniation itself is an acute event on top of chronic degeneration.\",\"Nerve compression or chemical irritation causes pain; the disc structure is still compromised.\"],\"degenerative_layers\":[{\"layer\":\"Disc matrix\",\"what_breaks\":\"Collagen and proteoglycans degrade; disc height drops.\"},{\"layer\":\"Inflammation\",\"what_breaks\":\"Chronic inflammatory signaling without resolution stalls repair.\"},{\"layer\":\"Nerves\",\"what_breaks\":\"Nerve roots get irritated or compressed as disc bulges.\"},{\"layer\":\"Blood supply\",\"what_breaks\":\"Discs are avascular — repair depends on diffusion; less supply = slower repair.\"}],\"note\":null},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"You have **Herniated disc** — breakdown is outpacing repair.\",\"**Therefore for you:** If that layer ","response":"{\n  \"slug\": \"tesamorelin-herniated-disc\",\n  \"title\": \"Tesamorelin for Herniated Disc: Evidence-Graded Look at GH Axis, Tissue Layers, and Repair Pathways\",\n  \"body\": \"## What's breaking down if you have Herniated disc\\n\\nA herniation occurs when disc material pushes through the outer ring. It often starts from degenerative disc changes where the weakened annulus tears under load. The herniation itself is an acute event on top of chronic degeneration. Nerve compression or chemical irritation causes pain while the disc structure remains compromised.\\n\\nDegeneration hits multiple layers. The disc matrix sees collagen and proteoglycans degrade, dropping disc height. Inflammation involves chronic signaling that stalls resolution and repair. Nerves suffer irritation or compression from the bulge. Blood supply is limited because discs are avascular, so repair relies on slow diffusion.\\n\\nBreakdown outruns repair in these layers, which is why the condition persists.\\n\\n## Why Tesamorelin might help you\\n\\n1. You have **Herniated disc** — breakdown is outpacing repair.\\n2. **Therefore for you:** If the GH axis / visceral fat layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\\n3. This article centers **Tesamorelin**; see other sections for BPC-157, TB-500, ARA-290 — different layers, same condition.\\n\\nTesamorelin stimulates endogenous growth hormone release in pulses. This pathway links to visceral fat reduction in published human trials for HIV lipodystrophy (human data). Reduced visceral fat can lower mechanical spinal load; each pound lost removes roughly four pounds of compressive force on the lumbar spine (mechanistic inference from body composition studies). No direct human trials exist on tesamorelin for disc herniation or degeneration (human tier: absent).\\n\\n## Why BPC-157 might help you\\n\\n1. You have **Herniated disc** — breakdown is outpacing repair.\\n2. **What keeps failing:** Poor blood supply","tokens_in":19489,"tokens_out":3550,"cost":0,"prev":"genesis","hash":"408848d78eeff1d7d0fc1a21cd0d0859e152e8a26c65aa4c64f600a23b7950dd"},{"ts":"2026-07-17T02:42:23.306Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-herniated-disc","response":"32 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"408848d78eeff1d7d0fc1a21cd0d0859e152e8a26c65aa4c64f600a23b7950dd","hash":"103f113b3ee3625b191dc7e6d6c929f9e6d6b9a8cb967cac2ceb9430f077e2dc"}],"energy":{"passes":2,"tokens_in":19489,"tokens_out":3550,"tokens_total":23039,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"103f113b3ee3625b191dc7e6d6c929f9e6d6b9a8cb967cac2ceb9430f077e2dc"},"posted_at":"2026-06-29T21:33:33.085Z","created_at":"2026-06-29T21:33:33.085Z","updated_at":"2026-07-17T02:42:23.306Z","machine":{"shape":"article.machine/v1","slug":"tesamorelin-herniated-disc","kind":"article","read":{"human":"https://miscsubjects.com/a/tesamorelin-herniated-disc","json":"https://miscsubjects.com/api/articles/tesamorelin-herniated-disc","bundle":"https://miscsubjects.com/api/articles/tesamorelin-herniated-disc/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":6,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tesamorelin-herniated-disc/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tesamorelin-herniated-disc","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tesamorelin-herniated-disc\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tesamorelin-herniated-disc\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tesamorelin-herniated-disc/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tesamorelin-herniated-disc\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tesamorelin-herniated-disc | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tesamorelin-herniated-disc","json":"/api/articles/tesamorelin-herniated-disc","markdown":"/api/articles/tesamorelin-herniated-disc/bundle?format=markdown","skill":"/api/articles/tesamorelin-herniated-disc/skill","topology":"/api/articles/tesamorelin-herniated-disc/topology","versions":"/api/articles/tesamorelin-herniated-disc/revisions","invocations":"/api/articles/tesamorelin-herniated-disc/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tesamorelin-herniated-disc","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"e57f37a9e4999ddac313b3a87badb68afe7d79f98fb0b5af77d4c625ed4075fc","object":{"object_type":"article-object","identity":{"id":"article:tesamorelin-herniated-disc","slug":"tesamorelin-herniated-disc","title":"Tesamorelin for Herniated Disc: Evidence-Graded Look at GH Axis, Tissue Layers, and Repair Pathways"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/tesamorelin-herniated-disc","role":"explain","audience":"human"},"skill":{"route":"/api/articles/tesamorelin-herniated-disc/skill","role":"direct behavior","audience":"model","content":"---\nname: tesamorelin-herniated-disc\ndescription: Apply the Tesamorelin for Herniated Disc: Evidence-Graded Look at GH Axis, Tissue Layers, and Repair Pathways article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Tesamorelin for Herniated Disc: Evidence-Graded Look at GH Axis, Tissue Layers, and Repair Pathways\n\nThis Skill is the behavioral expression of [the canonical article](/a/tesamorelin-herniated-disc). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/tesamorelin-herniated-disc.\n- Read claims and relationships at /api/articles/tesamorelin-herniated-disc/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Herniated disc A herniation occurs when disc material pushes through the outer ring. It often starts from degenerative disc changes where the weakened annulus tears under load. The herniation itself is an ac\n\n## Representations\n\n- Human: /a/tesamorelin-herniated-disc\n- JSON: /api/articles/tesamorelin-herniated-disc\n- Relationships: /api/articles/tesamorelin-herniated-disc/topology\n- History: /api/articles/tesamorelin-herniated-disc/revisions\n"},"json":{"route":"/api/articles/tesamorelin-herniated-disc","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/tesamorelin-herniated-disc/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","tesamorelin","herniated","disc"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/tesamorelin-herniated-disc/invocations?status=success","failure_events":"/api/articles/tesamorelin-herniated-disc/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"tesamorelin-herniated-disc","title":"Tesamorelin for Herniated Disc: Evidence-Graded Look at GH Axis, Tissue Layers, and Repair Pathways","body":"## What's breaking down if you have Herniated disc\n\nA herniation occurs when disc material pushes through the outer ring. It often starts from degenerative disc changes where the weakened annulus tears under load. The herniation itself is an acute event on top of chronic degeneration. Nerve compression or chemical irritation causes pain while the disc structure remains compromised.\n\nDegeneration hits multiple layers. The disc matrix sees collagen and proteoglycans degrade, dropping disc height. Inflammation involves chronic signaling that stalls resolution and repair. Nerves suffer irritation or compression from the bulge. Blood supply is limited because discs are avascular, so repair relies on slow diffusion.\n\nBreakdown outruns repair in these layers, which is why the condition persists.\n\n## Why Tesamorelin might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Therefore for you:** If the GH axis / visceral fat layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\n3. This article centers **Tesamorelin**; see other sections for BPC-157, TB-500, ARA-290 — different layers, same condition.\n\nTesamorelin stimulates endogenous growth hormone release in pulses. This pathway links to visceral fat reduction in published human trials for HIV lipodystrophy (human data). Reduced visceral fat can lower mechanical spinal load; each pound lost removes roughly four pounds of compressive force on the lumbar spine (mechanistic inference from body composition studies). No direct human trials exist on tesamorelin for disc herniation or degeneration (human tier: absent).\n\n## Why BPC-157 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\nAnimal studies show BPC-157 improves healing in rat spinal cord injury models and collagen organization in soft tissue (preclinical). No strong clinical evidence shows it repairs or reverses herniated discs in humans; most data remain preclinical (human tier: absent; preclinical tier: present).\n\n## Why TB-500 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Inflammation — Chronic inflammatory signaling without resolution stalls repair.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nReviews of animal models indicate thymosin beta-4 supports cell migration and may aid cartilage and disc cell regeneration in vitro or limited in vivo settings (preclinical). No dedicated human trials for disc herniation (human tier: absent).\n\n## Why ARA-290 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Nerves — Nerve roots get irritated or compressed as disc bulges.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\nPhase II human trials show ARA-290 increases corneal nerve fiber density and reduces neuropathic pain in small fiber neuropathy and sarcoidosis patients (human tier: present for neuropathy). No trials specifically address disc-related nerve compression (human tier for herniated disc: absent).\n\n## How these fit together\n\nThree degeneration layers — disc/tissue, inflammation/repair cells, nerves — map to three repair pathways in the recovery stack.\n- **Tesamorelin** → GH axis / visceral fat\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\nPrimary focus of this slug: **Tesamorelin**. Others are in scope because the same condition breaks down on multiple layers. The stack addresses separate layers without overlap in mechanism claims.\n\n## What the evidence actually shows\n\nHuman trials exist only for tesamorelin in visceral fat reduction and ARA-290 in neuropathy. All disc-specific data for BPC-157, TB-500, and direct tesamorelin effects on discs are preclinical or absent. No randomized controlled trials test any of these peptides for herniated disc outcomes in humans.\n\n## What scientists say\n\nPreclinical work on growth factors shows promise for disc matrix in animal models, but translation to humans remains unproven. Neuropathy trials for ARA-290 demonstrate objective nerve fiber regrowth via corneal confocal microscopy.\n\n## What people say on Reddit\n\nAnecdotal reports mention tesamorelin aiding back comfort via weight loss in users with herniated discs. BPC-157 and TB-500 users report perceived pain relief and mobility gains, though many note it may not alter the herniation itself (anecdotal tier).\n\n## What people say on X\n\nLimited posts echo similar anecdotal experiences with peptides for back issues, often tying relief to reduced inflammation or faster perceived recovery (anecdotal tier).\n\n## What we do not know\n\nLong-term structural changes to discs from any peptide remain unknown in humans. Dose-response, optimal stacking, and durability of any effects lack controlled data. Whether visceral fat reduction translates to measurable disc height preservation is untested.\n\n## Safety and limits\n\nTesamorelin carries FDA approval only for specific HIV lipodystrophy use with monitoring for glucose and IGF-1 changes. Other peptides discussed here lack regulatory approval for any use and exist only in research contexts. Individual responses vary; evidence does not support claims of reversal or cure.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tesamorelin-herniated-disc/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Tesamorelin reduces visceral adipose tissue in human HIV lipodystrophy trials.","section":"Why Tesamorelin might help you","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human data for its primary approved effect relevant to load reduction.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No direct human trials test tesamorelin for disc herniation or degeneration.","section":"Why Tesamorelin might help you","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies evidence gap for the specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"BPC-157 shows healing effects in rat spinal cord injury models.","section":"Why BPC-157 might help you","tier":"preclinical","source_ids":["s3"],"source_status":"sourced","why_material":"Supports angiogenesis and tissue repair layer discussion.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No strong clinical evidence shows BPC-157 repairs herniated discs in humans.","section":"Why BPC-157 might help you","tier":"human","source_ids":["s4","s2"],"source_status":"sourced","why_material":"Maintains separation of evidence tiers.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"ARA-290 increases corneal nerve fiber density in Phase II human neuropathy trials.","section":"Why ARA-290 might help you","tier":"human","source_ids":["s5"],"source_status":"sourced","why_material":"Provides human data for nerve layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"Reddit users report perceived benefits from tesamorelin via weight loss with herniated discs.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s6"],"source_status":"sourced","why_material":"Documents user anecdotes without endorsing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6766405/","title":"The Growth Hormone Releasing Hormone Analogue Tesamorelin...","quote":"In a separate study, tesamorelin reduced hepatic fat by a relative 40%...","summary":"Human trial data on visceral fat reduction.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"517421383b0b9a94333359325c85733320aaf145804b50d86f608410d0b2b0bb"},{"id":"s2","type":"other","url":"https://friscorehab.com/can-bpc-157-heal-a-herniated-disc-what-patients-with-back-pain-should-know/","title":"Can BPC-157 Heal a Herniated Disc?","quote":"However, there is currently no strong clinical evidence showing BPC-157 can repair or reverse a herniated disc in humans.","summary":"Notes absence of human evidence for peptides in disc conditions.","claim_ids":["c2","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"unverified","prev":"517421383b0b9a94333359325c85733320aaf145804b50d86f608410d0b2b0bb","hash":"dd32e0b4d92fb2af0d5ae1885d8f75f137501e1407379c93825bb167a2f305ef"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31266512/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury...","quote":"We focused on the therapeutic effects of the stable gastric pentadecapeptide BPC 157 in spinal cord injury using a rat model.","summary":"Rat study on BPC-157 for spinal injury.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"verified","prev":"dd32e0b4d92fb2af0d5ae1885d8f75f137501e1407379c93825bb167a2f305ef","hash":"e0d2dd7e3c3011c0adb7e823fa255608f56293cccad62bac7c9d8128c82b2c17"},{"id":"s4","type":"other","url":"https://friscorehab.com/can-bpc-157-heal-a-herniated-disc-what-patients-with-back-pain-should-know/","title":"Can BPC-157 Heal a Herniated Disc?","quote":"There is currently no strong clinical evidence showing BPC-157 can repair or reverse a herniated disc in humans.","summary":"Repeats human evidence gap.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"unverified","prev":"e0d2dd7e3c3011c0adb7e823fa255608f56293cccad62bac7c9d8128c82b2c17","hash":"501d3184b7a6e3e91363e95d15619bed8b2c9fd87ccc30e0d427e80563d054f2"},{"id":"s5","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","summary":"Human neuropathy trials for ARA-290.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"verified","prev":"501d3184b7a6e3e91363e95d15619bed8b2c9fd87ccc30e0d427e80563d054f2","hash":"58f712c772a069483799124887262438bf612899e2fb927398fb9b7fae269913"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1ebldar/herniated_disc/","title":"Herniated Disc : r/Peptides","quote":"Consider Tesamorelin . I started it to cut weight. Also have a herniated disc's in my lower back. Surprisingly, it seems to have helped with ...","summary":"User anecdote on tesamorelin and disc.","claim_ids":["c6"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:21:00.493Z","link_status":"ok","quote_status":"unverified","prev":"58f712c772a069483799124887262438bf612899e2fb927398fb9b7fae269913","hash":"d92627068c4fb51d6f5e524d11fb33cc4629d6f6a442e9ffd8ac61d8244856a4"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:21:01.255Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Tesamorelin for Herniated Disc: Evidence-Graded Look at GH Axis, Tissue Layers, and Repair Pathways","register":"source_ledger","body":"## What's breaking down if you have Herniated disc\n\nA herniation occurs when disc material pushes through the outer ring. It often starts from degenerative disc changes where the weakened annulus tears under load. The herniation itself is an acute event on top of chronic degeneration. Nerve compression or chemical irritation causes pain while the disc structure remains compromised.\n\nDegeneration hits multiple layers. The disc matrix sees collagen and proteoglycans degrade, dropping disc height. Inflammation involves chronic signaling that stalls resolution and repair. Nerves suffer irritation or compression from the bulge. Blood supply is limited because discs are avascular, so repair relies on slow diffusion.\n\nBreakdown outruns repair in these layers, which is why the condition persists.\n\n## Why Tesamorelin might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Therefore for you:** If the GH axis / visceral fat layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\n3. This article centers **Tesamorelin**; see other sections for BPC-157, TB-500, ARA-290 — different layers, same condition.\n\nTesamorelin stimulates endogenous growth hormone release in pulses. This pathway links to visceral fat reduction in published human trials for HIV lipodystrophy (human data). Reduced visceral fat can lower mechanical spinal load; each pound lost removes roughly four pounds of compressive force on the lumbar spine (mechanistic inference from body composition studies). No direct human trials exist on tesamorelin for disc herniation or degeneration (human tier: absent).\n\n## Why BPC-157 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\nAnimal studies show BPC-157 improves healing in rat spinal cord injury models and collagen organization in soft tissue (preclinical). No strong clinical evidence shows it repairs or reverses herniated discs in humans; most data remain preclinical (human tier: absent; preclinical tier: present).\n\n## Why TB-500 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Inflammation — Chronic inflammatory signaling without resolution stalls repair.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nReviews of animal models indicate thymosin beta-4 supports cell migration and may aid cartilage and disc cell regeneration in vitro or limited in vivo settings (preclinical). No dedicated human trials for disc herniation (human tier: absent).\n\n## Why ARA-290 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Nerves — Nerve roots get irritated or compressed as disc bulges.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\nPhase II human trials show ARA-290 increases corneal nerve fiber density and reduces neuropathic pain in small fiber neuropathy and sarcoidosis patients (human tier: present for neuropathy). No trials specifically address disc-related nerve compression (human tier for herniated disc: absent).\n\n## How these fit together\n\nThree degeneration layers — disc/tissue, inflammation/repair cells, nerves — map to three repair pathways in the recovery stack.\n- **Tesamorelin** → GH axis / visceral fat\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\nPrimary focus of this slug: **Tesamorelin**. Others are in scope because the same condition breaks down on multiple layers. The stack addresses separate layers without overlap in mechanism claims.\n\n## What the evidence actually shows\n\nHuman trials exist only for tesamorelin in visceral fat reduction and ARA-290 in neuropathy. All disc-specific data for BPC-157, TB-500, and direct tesamorelin effects on discs are preclinical or absent. No randomized controlled trials test any of these peptides for herniated disc outcomes in humans.\n\n## What scientists say\n\nPreclinical work on growth factors shows promise for disc matrix in animal models, but translation to humans remains unproven. Neuropathy trials for ARA-290 demonstrate objective nerve fiber regrowth via corneal confocal microscopy.\n\n## What people say on Reddit\n\nAnecdotal reports mention tesamorelin aiding back comfort via weight loss in users with herniated discs. BPC-157 and TB-500 users report perceived pain relief and mobility gains, though many note it may not alter the herniation itself (anecdotal tier).\n\n## What people say on X\n\nLimited posts echo similar anecdotal experiences with peptides for back issues, often tying relief to reduced inflammation or faster perceived recovery (anecdotal tier).\n\n## What we do not know\n\nLong-term structural changes to discs from any peptide remain unknown in humans. Dose-response, optimal stacking, and durability of any effects lack controlled data. Whether visceral fat reduction translates to measurable disc height preservation is untested.\n\n## Safety and limits\n\nTesamorelin carries FDA approval only for specific HIV lipodystrophy use with monitoring for glucose and IGF-1 changes. Other peptides discussed here lack regulatory approval for any use and exist only in research contexts. Individual responses vary; evidence does not support claims of reversal or cure.","claims":[{"id":"c1","text":"Tesamorelin reduces visceral adipose tissue in human HIV lipodystrophy trials.","section":"Why Tesamorelin might help you","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human data for its primary approved effect relevant to load reduction.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No direct human trials test tesamorelin for disc herniation or degeneration.","section":"Why Tesamorelin might help you","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies evidence gap for the specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"BPC-157 shows healing effects in rat spinal cord injury models.","section":"Why BPC-157 might help you","tier":"preclinical","source_ids":["s3"],"source_status":"sourced","why_material":"Supports angiogenesis and tissue repair layer discussion.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"No strong clinical evidence shows BPC-157 repairs herniated discs in humans.","section":"Why BPC-157 might help you","tier":"human","source_ids":["s4"],"source_status":"sourced","why_material":"Maintains separation of evidence tiers.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"ARA-290 increases corneal nerve fiber density in Phase II human neuropathy trials.","section":"Why ARA-290 might help you","tier":"human","source_ids":["s5"],"source_status":"sourced","why_material":"Provides human data for nerve layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"Reddit users report perceived benefits from tesamorelin via weight loss with herniated discs.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s6"],"source_status":"sourced","why_material":"Documents user anecdotes without endorsing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:21:00.873Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6766405/","title":"The Growth Hormone Releasing Hormone Analogue Tesamorelin...","quote":"In a separate study, tesamorelin reduced hepatic fat by a relative 40%...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"other","url":"https://friscorehab.com/can-bpc-157-heal-a-herniated-disc-what-patients-with-back-pain-should-know/","title":"Can BPC-157 Heal a Herniated Disc?","quote":"However, there is currently no strong clinical evidence showing BPC-157 can repair or reverse a herniated disc in humans.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31266512/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury...","quote":"We focused on the therapeutic effects of the stable gastric pentadecapeptide BPC 157 in spinal cord injury using a rat model.","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"other","url":"https://friscorehab.com/can-bpc-157-heal-a-herniated-disc-what-patients-with-back-pain-should-know/","title":"Can BPC-157 Heal a Herniated Disc?","quote":"There is currently no strong clinical evidence showing BPC-157 can repair or reverse a herniated disc in humans.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","link_status":"ok","quote_status":"verified"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1ebldar/herniated_disc/","title":"Herniated Disc : r/Peptides","quote":"Consider Tesamorelin . I started it to cut weight. Also have a herniated disc's in my lower back. Surprisingly, it seems to have helped with ...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":19489,"tokens_out":3550,"cost":0.03323625,"prev_hash":"genesis","hash":"8d168c4022dffff6ae1d277452e78fffd08ef3621fb07bcf3b9f4f3ea0409fa2"}],"provenance":[{"ts":"2026-06-29T23:21:01.255Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Herniated Disc\nSlug: tesamorelin-herniated-disc\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"multi_stack\",\"condition\":\"Herniated disc\",\"condition_key\":\"herniated-disc\",\"primary_peptide\":\"tesamorelin\",\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"},{\"id\":\"bpc-157\",\"name\":\"BPC-157\"},{\"id\":\"tb-500\",\"name\":\"TB-500\"},{\"id\":\"ara-290\",\"name\":\"ARA-290\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Herniated disc\",\"degenerative_why\":[\"A herniation is when disc material pushes through the outer ring.\",\"Often starts from degenerative disc changes — weakened annulus tears under load.\",\"The herniation itself is an acute event on top of chronic degeneration.\",\"Nerve compression or chemical irritation causes pain; the disc structure is still compromised.\"],\"degenerative_layers\":[{\"layer\":\"Disc matrix\",\"what_breaks\":\"Collagen and proteoglycans degrade; disc height drops.\"},{\"layer\":\"Inflammation\",\"what_breaks\":\"Chronic inflammatory signaling without resolution stalls repair.\"},{\"layer\":\"Nerves\",\"what_breaks\":\"Nerve roots get irritated or compressed as disc bulges.\"},{\"layer\":\"Blood supply\",\"what_breaks\":\"Discs are avascular — repair depends on diffusion; less supply = slower repair.\"}],\"note\":null},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"You have **Herniated disc** — breakdown is outpacing repair.\",\"**Therefore for you:** If that layer ","response":"{\n  \"slug\": \"tesamorelin-herniated-disc\",\n  \"title\": \"Tesamorelin for Herniated Disc: Evidence-Graded Look at GH Axis, Tissue Layers, and Repair Pathways\",\n  \"body\": \"## What's breaking down if you have Herniated disc\\n\\nA herniation occurs when disc material pushes through the outer ring. It often starts from degenerative disc changes where the weakened annulus tears under load. The herniation itself is an acute event on top of chronic degeneration. Nerve compression or chemical irritation causes pain while the disc structure remains compromised.\\n\\nDegeneration hits multiple layers. The disc matrix sees collagen and proteoglycans degrade, dropping disc height. Inflammation involves chronic signaling that stalls resolution and repair. Nerves suffer irritation or compression from the bulge. Blood supply is limited because discs are avascular, so repair relies on slow diffusion.\\n\\nBreakdown outruns repair in these layers, which is why the condition persists.\\n\\n## Why Tesamorelin might help you\\n\\n1. You have **Herniated disc** — breakdown is outpacing repair.\\n2. **Therefore for you:** If the GH axis / visceral fat layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\\n3. This article centers **Tesamorelin**; see other sections for BPC-157, TB-500, ARA-290 — different layers, same condition.\\n\\nTesamorelin stimulates endogenous growth hormone release in pulses. This pathway links to visceral fat reduction in published human trials for HIV lipodystrophy (human data). Reduced visceral fat can lower mechanical spinal load; each pound lost removes roughly four pounds of compressive force on the lumbar spine (mechanistic inference from body composition studies). No direct human trials exist on tesamorelin for disc herniation or degeneration (human tier: absent).\\n\\n## Why BPC-157 might help you\\n\\n1. You have **Herniated disc** — breakdown is outpacing repair.\\n2. **What keeps failing:** Poor blood supply","tokens_in":19489,"tokens_out":3550,"cost":0,"prev":"genesis","hash":"408848d78eeff1d7d0fc1a21cd0d0859e152e8a26c65aa4c64f600a23b7950dd"},{"ts":"2026-07-17T02:42:23.306Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-herniated-disc","response":"32 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"408848d78eeff1d7d0fc1a21cd0d0859e152e8a26c65aa4c64f600a23b7950dd","hash":"103f113b3ee3625b191dc7e6d6c929f9e6d6b9a8cb967cac2ceb9430f077e2dc"}],"energy":{"passes":2,"tokens_in":19489,"tokens_out":3550,"tokens_total":23039,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"103f113b3ee3625b191dc7e6d6c929f9e6d6b9a8cb967cac2ceb9430f077e2dc"},"posted_at":"2026-06-29T21:33:33.085Z","created_at":"2026-06-29T21:33:33.085Z","updated_at":"2026-07-17T02:42:23.306Z","machine":{"shape":"article.machine/v1","slug":"tesamorelin-herniated-disc","kind":"article","read":{"human":"https://miscsubjects.com/a/tesamorelin-herniated-disc","json":"https://miscsubjects.com/api/articles/tesamorelin-herniated-disc","bundle":"https://miscsubjects.com/api/articles/tesamorelin-herniated-disc/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":6,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tesamorelin-herniated-disc/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tesamorelin-herniated-disc","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tesamorelin-herniated-disc\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tesamorelin-herniated-disc\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tesamorelin-herniated-disc/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tesamorelin-herniated-disc\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tesamorelin-herniated-disc | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tesamorelin-herniated-disc","json":"/api/articles/tesamorelin-herniated-disc","markdown":"/api/articles/tesamorelin-herniated-disc/bundle?format=markdown","skill":"/api/articles/tesamorelin-herniated-disc/skill","topology":"/api/articles/tesamorelin-herniated-disc/topology","versions":"/api/articles/tesamorelin-herniated-disc/revisions","invocations":"/api/articles/tesamorelin-herniated-disc/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tesamorelin-herniated-disc","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"e57f37a9e4999ddac313b3a87badb68afe7d79f98fb0b5af77d4c625ed4075fc"}}}